Product Details
This product is not currently available, please contact us for further information.
Product Properties:
| Description | N |
|---|---|
| Description | N |
| DESI Drug Ind | -; - |
| DESI Drug Ind | -; - |
| Drug Category | USES: This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells. |
| Drug Category | USES: This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells. |
| Drug Type Code | COMMON BRAND NAME(S): Velcade |
| Drug Type Code | COMMON BRAND NAME(S): Velcade |
| HCPCS | 1 |
| HCPCS | 1 |
| Medical Coverage | - |
| Medical Coverage | - |
| Termination Date | (bor-TEZ-oh-mib) |
| Termination Date | (bor-TEZ-oh-mib) |
| Active Ingredients | 9985 bortezomib 179324697 |
| Active Ingredients | 9985 bortezomib 179324697 |
| AHFS Class | 10000000 ANTINEOPLASTIC AGENTS |
| AHFS Class | 10000000 ANTINEOPLASTIC AGENTS |
| DEA Class | NC |
| DEA Class | NC |
| Dose Form | VIAL (EA) |
| Dose Form | VIAL (EA) |
| Fine Line Class | 850085008510 All Rx Products |
| Fine Line Class | 850085008510 All Rx Products |
| Gen Code and Des | 52124 bortezomib INJECTION VIAL 3.5 MG |
| Gen Code and Des | 52124 bortezomib INJECTION VIAL 3.5 MG |
| Inactive Ingredients | 2272 mannitol 69658 |
| Inactive Ingredients | 2272 mannitol 69658 |
| OMP Family | - |
| OMP Family | - |
| Product Category | RX Pharmaceuticals |
| Product Category | RX Pharmaceuticals |
| Strength | 3.5MG |
| Strength | 3.5MG |
| Common Brand Name | J9041 |
| Common Brand Name | J9041 |
| Drug Interaction | - |
| Drug Interaction | - |
| Allocation Period | - |
| Allocation Period | - |
| Case Quantity | 135 |
| Case Quantity | 135 |
| Drug Form Pack Size | 1 |
| Drug Form Pack Size | 1 |
| Form | SINGLE DOSE VIAL |
| Form | SINGLE DOSE VIAL |
| Hazard Code | UN3077 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. |
| Hazard Code | UN3077 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. |
| Listed Chemical | - |
| Listed Chemical | - |
| NIOSH Code | NT1 ANTINEOPLASTIC DRUGS INCLUDING THOSE WITH MANUFACTURER'S SAFE HANDLING GUIDANCE (MSHG) |
| NIOSH Code | NT1 ANTINEOPLASTIC DRUGS INCLUDING THOSE WITH MANUFACTURER'S SAFE HANDLING GUIDANCE (MSHG) |
| Orange Book | AP Injectable aqueous solutions including dry powders, concentrated solutions or ready-to-use solutions are considered pharmaceutically and therapeutically equivalent if they produce the same concentration and are labeled similarly. |
| Orange Book | AP Injectable aqueous solutions including dry powders, concentrated solutions or ready-to-use solutions are considered pharmaceutically and therapeutically equivalent if they produce the same concentration and are labeled similarly. |
| Retail Pack Quantity | 1 |
| Retail Pack Quantity | 1 |
| Returnable Status | Returnable |
| Returnable Status | Returnable |
| Special Storage Cond | 00 None |
| Special Storage Cond | 00 None |
| Temp Zone | 10 Room Temperature |
| Temp Zone | 10 Room Temperature |
| Unit | EA |
| Unit | EA |
| Unit Size | - |
| Unit Size | - |
| How to Use | - |
| How to Use | - |
| Missed Dose | 1 |
| Missed Dose | 1 |
| Notes | EA |
| Notes | EA |
| Overdose | AP |
| Overdose | AP |
| Phonetic Pronunciation | COVERED WITH CARRIER DISCRETION |
| Phonetic Pronunciation | COVERED WITH CARRIER DISCRETION |
| Precautions | - |
| Precautions | - |
| Side Effects | - |
| Side Effects | - |
| Storage | 07/26/2022 |
| Storage | 07/26/2022 |
| Uses | Bortezomib inj, 0.1 MG |
| Uses | Bortezomib inj, 0.1 MG |
Frequently Asked Questions (FAQs)
The cost of BORTEZOMIB 3.5 MG SDV is $available for registerd members only
BORTEZOMIB 3.5 MG SDV is manufactured by Pfizer.
You can purchase BORTEZOMIB 3.5 MG SDV on our website at https://supplies.pipelinemedical.com/product/detail/bortezomib-3-5-mg-sdv-297801